Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson's disease

Research output: Chapter in Book/Report/Conference proceedingsConference proceedingpeer-review

Abstract


Original languageEnglish (Ireland)
Title of host publication Ir. J. Med. Sci. 174(1) es2 P26, Ireland .
Publication statusPublished - 2005

Cite this